Long-term kidney transplant graft survival-Making progress when most needed

Emilio D Poggio, Joshua J Augustine, Susana Arrigain, Daniel C Brennan, Jesse D Schold, Emilio D Poggio, Joshua J Augustine, Susana Arrigain, Daniel C Brennan, Jesse D Schold

Abstract

Current short-term kidney post-transplant survival rates are excellent, but longer-term outcomes have historically been unchanged. This study used data from the national Scientific Registry of Transplant Recipients (SRTR) and evaluated 1-year and 5-year graft survival and half-lives for kidney transplant recipients in the US. All adult (≥18 years) solitary kidney transplants (n = 331,216) from 1995 to 2017 were included in the analysis. Mean age was 49.4 years (SD +/-13.7), 60% male, and 25% Black. The overall (deceased and living donor) adjusted hazard of graft failure steadily decreased from 0.89 (95%CI: 0.88, 0.91) in era 2000-2004 to 0.46 (95%CI: 0.45, 0.47) for era 2014-2017 (1995-1999 as reference). Improvements in adjusted hazards of graft failure were more favorable for Blacks, diabetics and older recipients. Median survival for deceased donor transplants increased from 8.2 years in era 1995-1999 to an estimated 11.7 years in the most recent era. Living kidney donor transplant median survival increased from 12.1 years in 1995-1999 to an estimated 19.2 years for transplants in 2014-2017. In conclusion, these data show continuous improvement in long-term outcomes with more notable improvement among higher-risk subgroups, suggesting a narrowing in the gap for those disadvantaged after transplantation.

Keywords: clinical research / practice; epidemiology; health services and outcomes research; kidney transplantation / nephrology; registry / registry analysis; risk assessment / risk stratification.

© 2020 The American Society of Transplantation and the American Society of Transplant Surgeons.

References

REFERENCES

    1. Thomas E, Milton J, Cigarroa FG. The Advancing American Kidney Health Executive Order: An Opportunity to Enhance Organ Donation. JAMA. 2019;322(17):1645.
    1. Rosenberg ME. Presidential Address Kidney Week 2019: Winning the War on Kidney Diseases: The Time Is Now. Clin J Am Soc Nephrol. 2020;15(8):1213-1219.
    1. Loupy A, Aubert O, Reese PP, Bastien O, Bayer F, Jacquelinet C. Organ procurement and transplantation during the COVID-19 pandemic. Lancet. 2020;395(10237):e95-e96.
    1. UNOS/OPTN. 2020.
    1. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341(23):1725-1730.
    1. Merion RM, Ashby VB, Wolfe RA, et al. Deceased-donor characteristics and the survival benefit of kidney transplantation. JAMA. 2005;294(21):2726-2733.
    1. Landreneau K, Lee K, Landreneau MD. Quality of life in patients undergoing hemodialysis and renal transplantation-a meta-analytic review. Nephrol Nurs J. 2010;37(1):37-44.
    1. Tucker EL, Smith AR, Daskin MS, et al. Life and expectations post-kidney transplant: a qualitative analysis of patient responses. BMC Nephrol. 2019;20(1):175.
    1. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med. 2000;342(9):605-612.
    1. Meier-Kriesche HU, Schold JD, Kaplan B. Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant. 2004;4(8):1289-1295.
    1. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant. 2004;4(3):378-383.
    1. Lamb KE, Lodhi S, Meier-Kriesche HU. Long-term renal allograft survival in the United States: a critical reappraisal. Am J Transplant. 2011;11(3):450-462.
    1. Leppke S, Leighton T, Zaun D, et al. Scientific Registry of Transplant Recipients: collecting, analyzing, and reporting data on transplantation in the United States. Transplant Rev (Orlando). 2013;27(2):50-56.
    1. Massie AB, Segev DL. Rates of false flagging due to statistical artifact in CMS evaluations of transplant programs: results of a stochastic simulation. Am J Transplant. 2013;13(8):2044-2051.
    1. Schold JD, Andreoni KA, Chandraker AK, et al. Expanding clarity or confusion? Volatility of the 5-tier ratings assessing quality of transplant centers in the United States. Am J Transplant. 2018;18(6):1494-1501.
    1. Husain SA, Brennan C, Michelson A, et al. Patients prioritize waitlist over posttransplant outcomes when evaluating kidney transplant centers. Am J Transplant. 2018;18(11):2781-2790.
    1. Gill JS, Abichandani R, Kausz AT, Pereira BJ. Mortality after kidney transplant failure: the impact of non-immunologic factors. Kidney Int. 2002;62(5):1875-1883.
    1. Evans K, Coresh J, Bash LD, et al. Race differences in access to health care and disparities in incident chronic kidney disease in the US. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association. 2011;26(3):899-908.
    1. Patzer RE, Amaral S, Wasse H, Volkova N, Kleinbaum D, McClellan WM. Neighborhood poverty and racial disparities in kidney transplant waitlisting. J Am Soc Nephrol. 2009;20(6):1333-1340.
    1. Patzer RE, Perryman JP, Schrager JD, et al. The role of race and poverty on steps to kidney transplantation in the Southeastern United States. Am J Transplant. 2012;12(2):358-368.
    1. Purnell TS, Luo X, Kucirka LM, et al. Reduced Racial Disparity in Kidney Transplant Outcomes in the United States from 1990 to 2012. Journal of the American Society of Nephrology: JASN. 2016;27(8):2511-2518.
    1. Sehgal AR. Outcomes of renal replacement therapy among blacks and women. Am J Kidney Dis. 2000;35(4 Suppl 1):S148-152.
    1. Purnell TS, Luo X, Cooper LA, et al. Association of Race and Ethnicity With Live Donor Kidney Transplantation in the United States From 1995 to 2014. JAMA. 2018;319(1):49-61.
    1. Rose C, Gill J, Gill JS. Association of Kidney Transplantation with Survival in Patients with Long Dialysis Exposure. Clin J Am Soc Nephrol. 2017;12(12):2024-2031.
    1. Gill JS, Lan J, Dong J, et al. The survival benefit of kidney transplantation in obese patients. Am J Transplant. 2013;13(8):2083-2090.
    1. Heilman RL, Mathur A, Smith ML, Kaplan B, Reddy KS. Increasing the Use of Kidneys From Unconventional and High-Risk Deceased Donors. Am J Transplant. 2016;16(11):3086-3092.
    1. Heilman RL, Smith ML, Smith BH, et al. Long-term Outcomes Following Kidney Transplantation From Donors With Acute Kidney Injury. Transplantation. 2019;103(9):e263-e272.
    1. Massie AB, Luo X, Chow EK, Alejo JL, Desai NM, Segev DL. Survival benefit of primary deceased donor transplantation with high-KDPI kidneys. Am J Transplant. 2014;14(10):2310-2316.
    1. Reese PP, Abt PL, Blumberg EA, et al. Twelve-Month Outcomes After Transplant of Hepatitis C-Infected Kidneys Into Uninfected Recipients: A Single-Group Trial. Ann Intern Med. 2018;169(5):273-281.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi